Therapeutic drug monitoring of once daily aminoglycoside dosing: Comparison of two methods and investigation of the optimal blood sampling strategy

European Journal of Clinical Pharmacology

Volumn 70, Issue 7, 2014, Pages 829-837

  Nezic, Lana ^a   Derungs, Adrian ^a,b   Bruggisser, Marcel ^a   Tschudin Sutter, Sarah ^a   Krähenbühl, Stephan ^a,c   Haschke, Manuel ^a,c  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Amikacin; Gentamicin; Once daily dosing; Pharmacokinetics; Tobramycin

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; GENTAMICIN; TOBRAMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ALGORITHM; AREA UNDER THE CURVE; ARTICLE; BAYES THEOREM; BLOOD SAMPLING; CLINICAL ARTICLE; COMPUTER PROGRAM; DRUG BLOOD LEVEL; DRUG MONITORING; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; MAXIMUM PLASMA CONCENTRATION; PRIORITY JOURNAL; TIME TO MAXIMUM PLASMA CONCENTRATION; BIOLOGICAL MODEL; BLOOD; COMPARATIVE STUDY; DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; METABOLIC CLEARANCE RATE; MIDDLE AGED; PROCEDURES; PROSPECTIVE STUDY; YOUNG ADULT;

ADULT; AGED; ALGORITHMS; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; BAYES THEOREM; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; MODELS, BIOLOGICAL; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84903460087     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-014-1680-3     Document Type: Article

References (22)

1. Begg EJ, Barclay ML (1995) Aminoglycosides - 50 years on. Br J Clin Pharmacol 39(6):597-603
2. Avent ML, Rogers BA, Cheng AC, Paterson DL (2011) Current use of aminoglycosides: indications, pharmacokinetics and monitoring for toxicity. Intern Med J 41(6):441-449. doi:10.1111/j.1445-5994.2011.02452.x
3. Pagkalis S, Mantadakis E, Mavros MN, Ammari C, Falagas ME (2011) Pharmacological considerations for the proper clinical use of aminoglycosides. Drugs 71(17):2277-2294. doi:10.2165/11597020-000000000-00000
4. Hustinx WN, Hoepelman IM (1993) Aminoglycoside dosage regimens. Is once a day enough? Clin Pharmacokinet 25(6):427-432. doi:10.2165/00003088-199325060- 00002 (Pubitemid 23358030)
5. Bartal C, Danon A, Schlaeffer F, Reisenberg K, Alkan M, Smoliakov R, Sidi A, Almog Y (2003) Pharmacokinetic dosing of aminoglycosides: a controlled trial. Am J Med 114(3):194-198. doi:10.1016/S0002-9343(02)01476-6 (Pubitemid 36294004)
6. Barza M, Ioannidis JP, Cappelleri JC, Lau J (1996) Single ormultiple daily doses of aminoglycosides: a meta-analysis. BMJ 312(7027): 338-345. doi:10.1136/bmj.312.7027.33 (Pubitemid 26049400)
7. Hatala R, Dinh TT, Cook DJ (1997) Single daily dosing of aminoglycosides in immunocompromised adults: a systematic review. Clin Infect Dis 24(5):810-815. doi:10.1093/clinids/24.5.810
8. Mavros MN, Polyzos KA, Rafailidis PI, Falagas ME (2011) Once versus multiple daily dosing of aminoglycosides for patients with febrile neutropenia: a systematic review and meta-analysis. J Antimicrob Chemother 66(2):251-259. doi:10.1093/jac/dkq451
9. Munckhof WJ, Grayson ML, Turnidge JD (1996) A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses. J Antimicrob Chemother 37(4):645-663. doi:10.1093/jac/37.4.645 (Pubitemid 26134115)
10. Turnidge J (2003) Pharmacodynamics and dosing of aminoglycosides. Infect Dis Clin North Am 17(3):503-528. doi:10.1016/S0891-5520(03)00057-6
11. Bertino JS Jr, Booker LA, Franck PA, Jenkins PL, Franck KR, Nafziger AN (1993) Incidence of and significant risk factors for aminoglycoside-associated nephrotoxicity in patients dosed by using individualized pharmacokinetic monitoring. J Infect Dis 167(1):173-179. doi:10.1093/infdis/167.1.173 (Pubitemid 23002853)
12. Croes S, Koop AH, van Gils SA, Neef C (2012) Efficacy, nephrotoxicity and ototoxicity of aminoglycosides, mathematically modelled for modelling-supported therapeutic drug monitoring. Eur J Pharm Sci 45(1-2):90-100. doi:10.1016/j.ejps.2011.10.022
13. Begg EJ, Barclay ML, Duffull SB (1995) A suggested approach to once-daily aminoglycoside dosing. Br J Clin Pharmacol 39(6):605-609. doi:10.1111/j.1365- 2125.1995.tb05719.x
14. Begg EJ, Barclay ML, Kirkpatrick CM (2001) The therapeutic monitoring of antimicrobial agents. Br J Clin Pharmacol 52(Suppl 1): 35S-43S. doi:10.1111/j.1365-2125.2001.00377.x (Pubitemid 32823030)
15. Barclay ML, Kirkpatrick CM, Begg EJ (1999) Once daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored? Clin Pharmacokinet 36(2):89-98. doi:10.2165/00003088-199936020-00001 (Pubitemid 29121683)
16. Coulthard KP, Peckham DG, Conway SP, Smith CA, Bell J, Turnidge J (2007) Therapeutic drug monitoring of once daily tobramycin in cystic fibrosis-caution with trough concentrations. J Cyst Fibros 6(2):125-130. doi:10.1016/j.jcf.2006. 05.015 (Pubitemid 46381653)
17. Barclay ML, Duffull SB, Begg EJ, Buttimore RC (1995) Experience of once-daily aminoglycoside dosing using a target area under the concentration-time curve. Aust N Z J Med 25(3):230-235. doi:10.1111/j.1445-5994. 1995.tb01529.x
18. Burton ME, Brater DC, Chen PS, Day RB, Huber PJ, Vasko MR (1985) A Bayesian feedback method of aminoglycoside dosing. Clin Pharmacol Ther 37(3):349-357. doi:10.1038/clpt.1985.51 (Pubitemid 15239041)
19. Wong C, Kumar SS, Graham GG, Begg EJ, Chin PK, Brett J, Ray JE, Marriott DJ, Williams KM, Day RO (2013) Comparing dose prediction software used to manage gentamicin dosing. Intern Med J 43(5): 519-525. doi:10.1111/imj.12067
20. Zhang Y, Huo M, Zhou J, Xie S (2010) PKSolver: An add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Methods Prog Biomed 99(3):306-314. doi:10.1016/j.cmpb.2010.01.007
21. Sawchuk RJ, Zaske DE, Cipolle RJ, Wargin WA, Strate RG (1977) Kinetic model for gentamicin dosing with the use of individual patient parameters. Clin Pharmacol Ther 21(3):362-369 (Pubitemid 8064258)
22. Fuchs A, Csajka C, Thoma Y, Buclin T, Widmer N (2013) Benchmarking therapeutic drug monitoring software: a review of available computer tools. Clin Pharmacokinet 52(1):9-22. doi:10.1007/s40262-012-0020-y